Today, the Department of Drug and Alcohol Programs (DDAP) has released a guidance bulletin on the use of telehealth for outpatient drug and alcohol services funded by the Single County Authority. Please contact Jack Phillips with any questions.
DDAP is accepting applications from SCAs who shall expand or create a collaborative between local law enforcement, treatment professionals, and recovery support providers to establish a diversion program. Active and engaged relationships with the local District Attorney, identified local police departments, Opioid Use Disorder (OUD) treatment providers, and Certified Recovery Specialists (CRS) shall be foundational to such an initiative. Rather than experiencing legal consequences for an OUD, individuals shall receive treatment and support services for the underlying cause of the arrest. Applications are due by December 5.
Learn more on the Funding Opportunities page.
The Department of Drug and Alcohol Programs is providing the opportunity for public comment on the Pennsylvania Substance Abuse Prevention and Treatment Block Grant (SABG) Submission. This submission will occur in three parts: The Substance Abuse Prevention and Treatment (SAPT) Plan which is currently available in draft and available for review, the SAPT Report which will be posted in November, and the Annual Synar Report which will be made available in December.
In accordance with legislation that passed in 1972, the Department of Drug and Alcohol Programs (DDAP) is required to develop a State Plan and to update it annually. The department has posted a request for public comments on the 2019–2022 draft state plan. Comments are due Monday, September 16 to Jordan Lewis. We request that members also copy RCPA Children’s Division Director Jim Sharp on any comments submitted to DDAP. If you have any questions, please contact Jim Sharp.
The Pennsylvania Department of Health (DOH), in conjunction with the Pennsylvania Department of Drug and Alcohol Programs (DDAP), will be hosting eight regional Medication Assisted Treatment (MAT) Summits this fall. The purpose of these summits is to promote awareness of MAT options for opioid use disorder and to increase the number of practitioners using the waiver to prescribe buprenorphine in an office-based setting.
Participants in the summits will include physicians, physician assistants, and nurse practitioners, as well as administrative and clinical support staff in their practices. Other industry stakeholders could also benefit and are welcome to attend.
A web page has been established on DDAP’s website which includes the summit dates, counties in each region, and Save the Date flyers for each summit. This web page will be updated as more information becomes available.
Attendance is free, and registration will open in early September. Another email will be sent when registration opens. Questions can be directed to this email.
Join RCPA in supporting National Recovery Month in September. Immediately following the kick-off event, RCPA will be holding their Drug & Alcohol Division meeting on September 4, 2019 at 1:00 pm at the RCPA office, 777 E Park Drive, Harrisburg, PA. Please register to attend our meeting which will feature guest speakers from the Department of Drug and Alcohol Programs and the Office of Mental Health and Substance Abuse Services. Please forward any agenda items to Tina Miletic for review and discussion. We look forward to your participation.
The Department of Drug and Alcohol Programs (DDAP) has announced a new Grant Initiative Funding Opportunity for Pregnancy Support Services. Eligible applicants must be able to serve pregnant women and postpartum women with opioid use disorder (OUD). Single County Authorities are not eligible to apply under this funding announcement. Applications are due by September 12, 2019 at 5:00 pm.
SUMMARY: DDAP is accepting applications for providers who will provide pregnancy support services or make referrals to address the needs of pregnant and postpartum women with OUD. In addition, these community providers will facilitate or make referrals for outpatient Medication-Assisted Treatment.
The Department of Drug and Alcohol Programs (DDAP) released a policy bulletin ensuring that treatment services continue during a grievance. The bulletin states that in the event an individual grieves a treatment funding decision related to a reduction or termination of services or length of stay in treatment, the SCA is required to continue funding treatment services at the current level of engagement until the appeal is resolved. This applies to all treatment services, including the provision of Medication Assisted Treatment (MAT).
All SCAs will include this updated requirement in their grievance and appeal policy and process, inform individuals of and have them sign-off on having received notification of the policy and process. SCAs must also inform contracted treatment providers of this change in requirements, effective immediately. Contact DDAP with any questions.